ESROGLIM M 2 FORTE Tablets combine Metformin Hydrochloride 1000 mg (prolonged-release) and Glimepiride 2 mg in a single bilayered formulation, offering a powerful solution for type 2 diabetes management. Designed for both immediate and sustained action, this combination helps maintain stable blood sugar levels throughout the day.
Form: Uncoated bilayered tablets
Composition: Metformin Hydrochloride 1000 mg (prolonged-release) + Glimepiride 2 mg
Colour: Quinoline Yellow WS
Pack Size: 10 × 15 Tablets
MRP: ₹165/-
Metformin improves insulin sensitivity and reduces glucose production in the liver, while Glimepiride stimulates the pancreas to release more insulin. This dual-action therapy addresses both insulin resistance and low insulin production—two key challenges in type 2 diabetes.
✔ Dual-Action Formula for enhanced blood sugar control
✔ Prolonged-Release Metformin for all-day glucose stability
✔ Bilayered Design combining immediate & sustained effects
✔ Reduces Insulin Resistance for better glucose utilization
✔ Convenient Once-Daily Dosing for improved compliance
Unlike standard diabetes medicines, this combination reduces the need for multiple tablets, improving patient convenience and treatment adherence. It is ideal for adults who need effective glycemic control with fewer fluctuations in sugar levels.
